|
|
Article: Studies from University of Edinburgh, Queen's Medical Research Institute update current data on life sciences.
- Article from:
- Biotech Week
- Article date:
- November 18, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Scientists discuss in 'Hypothalamic-pituitary-adrenal axis abnormalities in response to deletion of 11beta-HSD1 is strain-dependent' new findings in life sciences. "Inter-individual differences in hypothalamic-pituitary-adrenal (HPA) axis activity underlie differential vulnerability to neuropsychiatric and metabolic disorders, although the basis of this variation is poorly understood. 11beta-Hydroxysteroid dehydrogenase type 1 (11beta-HSD1) has previously been shown to influence HPA axis activity. 129/MF1 mice null for 11beta-HSD1 (129/MF1 HSD1(-/-)) have greatly increased adrenal gland size and altered HPA activity, consistent with reduced glucocorticoid negative ...
Related newspaper, magazine, and journal articles:
|
|
Article: Research in the area of life sciences reported from ...
Obesity, Fitness & Wellness Week;
June 20, 2009 ;
700+ words
... ... Disease Markers report (see also Life Sciences). "The study included 50 patients ... and colleagues, Institute for Medical Research. The researchers concluded ... Netherlands. Keywords: Serbia, Life Sciences, Cerebral Infarction, Brain ...
|
|